Consulting Engagements

• University City Science Center – QED Proof-of-Concept Program Business Advisor
• Immunocongated therapeutic that targets cancer stem cells
• Nanotechnology-enabled lab-on-a-chip  (Funded Round 3)
• Biocidal treatment for medic al textiles (Funded Round 4)
  
  
• Emerging developments and trends in the treatment of glaucoma
  
  
• Emerging developments and trends in the treatment and diagnosis of Alzheimer’s disease
  
  
• Regulatory issues concerning the use of biomarkers and clinical trial design
  
  
• Marketing strategy for implementation of nanotechnology for drug delivery as a product line extension
  
  
• Health-care reform in emerging markets:  Implications for multinational pharmaceutical companies
  
  
• Gene barcode for microarray analysis (business guidance for market analysis)
  
  
• Multiplexed molecular diagnostic tests for detection of infectious diseases (business guidance for market analysis)
  
  
• EM-CCD cameras for single molecule spectroscopy and imaging (market advisory voice-of-customer survey)
  
  
• Regulated self-assembly of  proteins  (marketable business opportunities worthy of patent prosecution)